COVID-19 Is Exacerbating Antibiotic Use – And Antimicrobial Resistance Is Rising Fast, WHO Warns 02/06/2020 Svĕt Lustig Vijay As the COVID-19 pandemic spawns increased antibiotic use all over the world, more drug-resistant microbes are bound to bite us back , said Dr. Tedros at a WHO press conference on Monday. The repercussions on disease treatment and deaths will be severe, given that the world is running out of effective ways to treat antimicrobial […] Continue reading -> US To ‘Terminate Relationship’ With The World Health Organization – Announcement Coincides With WHO Launch Of ‘COVID-19 Technology Access Pool’ 29/05/2020 Grace Ren US President Donald Trump announced on Friday he was terminating the US’ relationship with the World Health Organization. Trump’s declaration came hours after WHO’s celebratory launch of a new ‘Solidarity Call to Action ,’ urging countries to make patents and data for COVID-19 treatments and vaccines freely available as ‘global public goods.’ Some 37 countries […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> AstraZeneca & Pfizer Announce Plans For Phase III COVID-19 Vaccine Trials 28/05/2020 Svĕt Lustig Vijay The UK-based Pharma firm AstraZeneca and US-based Pfizer announced they are planning to start Phase III trials as early as July for an experimental COVID-19 vaccine in the United States and the United Kingdom. The massive trials would enroll over 30,000 people, and AstraZeneca’s hope is to have an effective vaccine by the end of […] Continue reading -> WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial – After Lancet Study Finds Higher Mortality Rate Among Patients Getting The Drug 25/05/2020 Grace Ren This story was updated 4 June to reflect the Lancet study’s retraction. Enrollment of new patients in the hydroxychloroquine (HCQ) arm of the World Health Organization’s Global COVID-19 Solidarity Trial will be put on pause, as the trial’s oversight committee reviews all available data on COVID-19 and hydroxychloroquine, WHO Director-General Dr. Tedros Adhanom Ghebreyesus said […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Hydroxychloroquine May Cause More Harm Than Benefit To COVID-19 Patients, Says New Lancet Study 22/05/2020 Svĕt Lustig Vijay & Grace Ren This story was updated 4 June to reflect the paper’s retraction. New research published in The Lancet on Friday found that hydroxychloroquine and chloroquine has ‘no benefit’ for coronavirus patients, and could even increase the risk of heart arrhythmias and mortality. The study was retracted by three of its authors on June 4, due to […] Continue reading -> Pharma Under The Microscope In The COVID-19 Crisis 19/05/2020 Elaine Ruth Fletcher Now, more than ever, the pharma industry has been thrust into the limelight – as the world races to find new drugs and a hoped-for vaccine to beat COVID-19 and ensure universal access to critical treatment. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), talks about the old-new tensions […] Continue reading -> WHO, Costa Rica & Chile Announce Official Launch Of COVID-19 Intellectual Property Pool 15/05/2020 Grace Ren Costa Rica and the World Health Organization today announced that a voluntary intellectual property pool for COVID-19 related technologies will be officially launched on May 29, following the World Health Assembly on May 18 to 19. The official launch comes more than two months after the Costa Rican president and health minister first published an […] Continue reading -> US Food & Drug Administration Approves New Sedative Product For Emergency Use In Ventilated COVID-19 Patients; Doctors Question Remdesivir Eligibility Criteria 12/05/2020 Grace Ren Amidst the global shortage of ventilators, personal protective equipment, and diagnostics; sedatives, used to keep severe COVID-19 patients who require invasive ventilation continuously sedated, are in increasingly short supply around the United States. The US Food and Drug Administration (FDA) on Monday issued an emergency use authorization (EUA) for Fresenius Propoven 2% (propofol 20 mg/mL) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US To ‘Terminate Relationship’ With The World Health Organization – Announcement Coincides With WHO Launch Of ‘COVID-19 Technology Access Pool’ 29/05/2020 Grace Ren US President Donald Trump announced on Friday he was terminating the US’ relationship with the World Health Organization. Trump’s declaration came hours after WHO’s celebratory launch of a new ‘Solidarity Call to Action ,’ urging countries to make patents and data for COVID-19 treatments and vaccines freely available as ‘global public goods.’ Some 37 countries […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> AstraZeneca & Pfizer Announce Plans For Phase III COVID-19 Vaccine Trials 28/05/2020 Svĕt Lustig Vijay The UK-based Pharma firm AstraZeneca and US-based Pfizer announced they are planning to start Phase III trials as early as July for an experimental COVID-19 vaccine in the United States and the United Kingdom. The massive trials would enroll over 30,000 people, and AstraZeneca’s hope is to have an effective vaccine by the end of […] Continue reading -> WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial – After Lancet Study Finds Higher Mortality Rate Among Patients Getting The Drug 25/05/2020 Grace Ren This story was updated 4 June to reflect the Lancet study’s retraction. Enrollment of new patients in the hydroxychloroquine (HCQ) arm of the World Health Organization’s Global COVID-19 Solidarity Trial will be put on pause, as the trial’s oversight committee reviews all available data on COVID-19 and hydroxychloroquine, WHO Director-General Dr. Tedros Adhanom Ghebreyesus said […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Hydroxychloroquine May Cause More Harm Than Benefit To COVID-19 Patients, Says New Lancet Study 22/05/2020 Svĕt Lustig Vijay & Grace Ren This story was updated 4 June to reflect the paper’s retraction. New research published in The Lancet on Friday found that hydroxychloroquine and chloroquine has ‘no benefit’ for coronavirus patients, and could even increase the risk of heart arrhythmias and mortality. The study was retracted by three of its authors on June 4, due to […] Continue reading -> Pharma Under The Microscope In The COVID-19 Crisis 19/05/2020 Elaine Ruth Fletcher Now, more than ever, the pharma industry has been thrust into the limelight – as the world races to find new drugs and a hoped-for vaccine to beat COVID-19 and ensure universal access to critical treatment. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), talks about the old-new tensions […] Continue reading -> WHO, Costa Rica & Chile Announce Official Launch Of COVID-19 Intellectual Property Pool 15/05/2020 Grace Ren Costa Rica and the World Health Organization today announced that a voluntary intellectual property pool for COVID-19 related technologies will be officially launched on May 29, following the World Health Assembly on May 18 to 19. The official launch comes more than two months after the Costa Rican president and health minister first published an […] Continue reading -> US Food & Drug Administration Approves New Sedative Product For Emergency Use In Ventilated COVID-19 Patients; Doctors Question Remdesivir Eligibility Criteria 12/05/2020 Grace Ren Amidst the global shortage of ventilators, personal protective equipment, and diagnostics; sedatives, used to keep severe COVID-19 patients who require invasive ventilation continuously sedated, are in increasingly short supply around the United States. The US Food and Drug Administration (FDA) on Monday issued an emergency use authorization (EUA) for Fresenius Propoven 2% (propofol 20 mg/mL) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> AstraZeneca & Pfizer Announce Plans For Phase III COVID-19 Vaccine Trials 28/05/2020 Svĕt Lustig Vijay The UK-based Pharma firm AstraZeneca and US-based Pfizer announced they are planning to start Phase III trials as early as July for an experimental COVID-19 vaccine in the United States and the United Kingdom. The massive trials would enroll over 30,000 people, and AstraZeneca’s hope is to have an effective vaccine by the end of […] Continue reading -> WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial – After Lancet Study Finds Higher Mortality Rate Among Patients Getting The Drug 25/05/2020 Grace Ren This story was updated 4 June to reflect the Lancet study’s retraction. Enrollment of new patients in the hydroxychloroquine (HCQ) arm of the World Health Organization’s Global COVID-19 Solidarity Trial will be put on pause, as the trial’s oversight committee reviews all available data on COVID-19 and hydroxychloroquine, WHO Director-General Dr. Tedros Adhanom Ghebreyesus said […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Hydroxychloroquine May Cause More Harm Than Benefit To COVID-19 Patients, Says New Lancet Study 22/05/2020 Svĕt Lustig Vijay & Grace Ren This story was updated 4 June to reflect the paper’s retraction. New research published in The Lancet on Friday found that hydroxychloroquine and chloroquine has ‘no benefit’ for coronavirus patients, and could even increase the risk of heart arrhythmias and mortality. The study was retracted by three of its authors on June 4, due to […] Continue reading -> Pharma Under The Microscope In The COVID-19 Crisis 19/05/2020 Elaine Ruth Fletcher Now, more than ever, the pharma industry has been thrust into the limelight – as the world races to find new drugs and a hoped-for vaccine to beat COVID-19 and ensure universal access to critical treatment. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), talks about the old-new tensions […] Continue reading -> WHO, Costa Rica & Chile Announce Official Launch Of COVID-19 Intellectual Property Pool 15/05/2020 Grace Ren Costa Rica and the World Health Organization today announced that a voluntary intellectual property pool for COVID-19 related technologies will be officially launched on May 29, following the World Health Assembly on May 18 to 19. The official launch comes more than two months after the Costa Rican president and health minister first published an […] Continue reading -> US Food & Drug Administration Approves New Sedative Product For Emergency Use In Ventilated COVID-19 Patients; Doctors Question Remdesivir Eligibility Criteria 12/05/2020 Grace Ren Amidst the global shortage of ventilators, personal protective equipment, and diagnostics; sedatives, used to keep severe COVID-19 patients who require invasive ventilation continuously sedated, are in increasingly short supply around the United States. The US Food and Drug Administration (FDA) on Monday issued an emergency use authorization (EUA) for Fresenius Propoven 2% (propofol 20 mg/mL) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
AstraZeneca & Pfizer Announce Plans For Phase III COVID-19 Vaccine Trials 28/05/2020 Svĕt Lustig Vijay The UK-based Pharma firm AstraZeneca and US-based Pfizer announced they are planning to start Phase III trials as early as July for an experimental COVID-19 vaccine in the United States and the United Kingdom. The massive trials would enroll over 30,000 people, and AstraZeneca’s hope is to have an effective vaccine by the end of […] Continue reading -> WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial – After Lancet Study Finds Higher Mortality Rate Among Patients Getting The Drug 25/05/2020 Grace Ren This story was updated 4 June to reflect the Lancet study’s retraction. Enrollment of new patients in the hydroxychloroquine (HCQ) arm of the World Health Organization’s Global COVID-19 Solidarity Trial will be put on pause, as the trial’s oversight committee reviews all available data on COVID-19 and hydroxychloroquine, WHO Director-General Dr. Tedros Adhanom Ghebreyesus said […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Hydroxychloroquine May Cause More Harm Than Benefit To COVID-19 Patients, Says New Lancet Study 22/05/2020 Svĕt Lustig Vijay & Grace Ren This story was updated 4 June to reflect the paper’s retraction. New research published in The Lancet on Friday found that hydroxychloroquine and chloroquine has ‘no benefit’ for coronavirus patients, and could even increase the risk of heart arrhythmias and mortality. The study was retracted by three of its authors on June 4, due to […] Continue reading -> Pharma Under The Microscope In The COVID-19 Crisis 19/05/2020 Elaine Ruth Fletcher Now, more than ever, the pharma industry has been thrust into the limelight – as the world races to find new drugs and a hoped-for vaccine to beat COVID-19 and ensure universal access to critical treatment. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), talks about the old-new tensions […] Continue reading -> WHO, Costa Rica & Chile Announce Official Launch Of COVID-19 Intellectual Property Pool 15/05/2020 Grace Ren Costa Rica and the World Health Organization today announced that a voluntary intellectual property pool for COVID-19 related technologies will be officially launched on May 29, following the World Health Assembly on May 18 to 19. The official launch comes more than two months after the Costa Rican president and health minister first published an […] Continue reading -> US Food & Drug Administration Approves New Sedative Product For Emergency Use In Ventilated COVID-19 Patients; Doctors Question Remdesivir Eligibility Criteria 12/05/2020 Grace Ren Amidst the global shortage of ventilators, personal protective equipment, and diagnostics; sedatives, used to keep severe COVID-19 patients who require invasive ventilation continuously sedated, are in increasingly short supply around the United States. The US Food and Drug Administration (FDA) on Monday issued an emergency use authorization (EUA) for Fresenius Propoven 2% (propofol 20 mg/mL) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial – After Lancet Study Finds Higher Mortality Rate Among Patients Getting The Drug 25/05/2020 Grace Ren This story was updated 4 June to reflect the Lancet study’s retraction. Enrollment of new patients in the hydroxychloroquine (HCQ) arm of the World Health Organization’s Global COVID-19 Solidarity Trial will be put on pause, as the trial’s oversight committee reviews all available data on COVID-19 and hydroxychloroquine, WHO Director-General Dr. Tedros Adhanom Ghebreyesus said […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Hydroxychloroquine May Cause More Harm Than Benefit To COVID-19 Patients, Says New Lancet Study 22/05/2020 Svĕt Lustig Vijay & Grace Ren This story was updated 4 June to reflect the paper’s retraction. New research published in The Lancet on Friday found that hydroxychloroquine and chloroquine has ‘no benefit’ for coronavirus patients, and could even increase the risk of heart arrhythmias and mortality. The study was retracted by three of its authors on June 4, due to […] Continue reading -> Pharma Under The Microscope In The COVID-19 Crisis 19/05/2020 Elaine Ruth Fletcher Now, more than ever, the pharma industry has been thrust into the limelight – as the world races to find new drugs and a hoped-for vaccine to beat COVID-19 and ensure universal access to critical treatment. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), talks about the old-new tensions […] Continue reading -> WHO, Costa Rica & Chile Announce Official Launch Of COVID-19 Intellectual Property Pool 15/05/2020 Grace Ren Costa Rica and the World Health Organization today announced that a voluntary intellectual property pool for COVID-19 related technologies will be officially launched on May 29, following the World Health Assembly on May 18 to 19. The official launch comes more than two months after the Costa Rican president and health minister first published an […] Continue reading -> US Food & Drug Administration Approves New Sedative Product For Emergency Use In Ventilated COVID-19 Patients; Doctors Question Remdesivir Eligibility Criteria 12/05/2020 Grace Ren Amidst the global shortage of ventilators, personal protective equipment, and diagnostics; sedatives, used to keep severe COVID-19 patients who require invasive ventilation continuously sedated, are in increasingly short supply around the United States. The US Food and Drug Administration (FDA) on Monday issued an emergency use authorization (EUA) for Fresenius Propoven 2% (propofol 20 mg/mL) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Hydroxychloroquine May Cause More Harm Than Benefit To COVID-19 Patients, Says New Lancet Study 22/05/2020 Svĕt Lustig Vijay & Grace Ren This story was updated 4 June to reflect the paper’s retraction. New research published in The Lancet on Friday found that hydroxychloroquine and chloroquine has ‘no benefit’ for coronavirus patients, and could even increase the risk of heart arrhythmias and mortality. The study was retracted by three of its authors on June 4, due to […] Continue reading -> Pharma Under The Microscope In The COVID-19 Crisis 19/05/2020 Elaine Ruth Fletcher Now, more than ever, the pharma industry has been thrust into the limelight – as the world races to find new drugs and a hoped-for vaccine to beat COVID-19 and ensure universal access to critical treatment. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), talks about the old-new tensions […] Continue reading -> WHO, Costa Rica & Chile Announce Official Launch Of COVID-19 Intellectual Property Pool 15/05/2020 Grace Ren Costa Rica and the World Health Organization today announced that a voluntary intellectual property pool for COVID-19 related technologies will be officially launched on May 29, following the World Health Assembly on May 18 to 19. The official launch comes more than two months after the Costa Rican president and health minister first published an […] Continue reading -> US Food & Drug Administration Approves New Sedative Product For Emergency Use In Ventilated COVID-19 Patients; Doctors Question Remdesivir Eligibility Criteria 12/05/2020 Grace Ren Amidst the global shortage of ventilators, personal protective equipment, and diagnostics; sedatives, used to keep severe COVID-19 patients who require invasive ventilation continuously sedated, are in increasingly short supply around the United States. The US Food and Drug Administration (FDA) on Monday issued an emergency use authorization (EUA) for Fresenius Propoven 2% (propofol 20 mg/mL) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Hydroxychloroquine May Cause More Harm Than Benefit To COVID-19 Patients, Says New Lancet Study 22/05/2020 Svĕt Lustig Vijay & Grace Ren This story was updated 4 June to reflect the paper’s retraction. New research published in The Lancet on Friday found that hydroxychloroquine and chloroquine has ‘no benefit’ for coronavirus patients, and could even increase the risk of heart arrhythmias and mortality. The study was retracted by three of its authors on June 4, due to […] Continue reading -> Pharma Under The Microscope In The COVID-19 Crisis 19/05/2020 Elaine Ruth Fletcher Now, more than ever, the pharma industry has been thrust into the limelight – as the world races to find new drugs and a hoped-for vaccine to beat COVID-19 and ensure universal access to critical treatment. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), talks about the old-new tensions […] Continue reading -> WHO, Costa Rica & Chile Announce Official Launch Of COVID-19 Intellectual Property Pool 15/05/2020 Grace Ren Costa Rica and the World Health Organization today announced that a voluntary intellectual property pool for COVID-19 related technologies will be officially launched on May 29, following the World Health Assembly on May 18 to 19. The official launch comes more than two months after the Costa Rican president and health minister first published an […] Continue reading -> US Food & Drug Administration Approves New Sedative Product For Emergency Use In Ventilated COVID-19 Patients; Doctors Question Remdesivir Eligibility Criteria 12/05/2020 Grace Ren Amidst the global shortage of ventilators, personal protective equipment, and diagnostics; sedatives, used to keep severe COVID-19 patients who require invasive ventilation continuously sedated, are in increasingly short supply around the United States. The US Food and Drug Administration (FDA) on Monday issued an emergency use authorization (EUA) for Fresenius Propoven 2% (propofol 20 mg/mL) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pharma Under The Microscope In The COVID-19 Crisis 19/05/2020 Elaine Ruth Fletcher Now, more than ever, the pharma industry has been thrust into the limelight – as the world races to find new drugs and a hoped-for vaccine to beat COVID-19 and ensure universal access to critical treatment. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), talks about the old-new tensions […] Continue reading -> WHO, Costa Rica & Chile Announce Official Launch Of COVID-19 Intellectual Property Pool 15/05/2020 Grace Ren Costa Rica and the World Health Organization today announced that a voluntary intellectual property pool for COVID-19 related technologies will be officially launched on May 29, following the World Health Assembly on May 18 to 19. The official launch comes more than two months after the Costa Rican president and health minister first published an […] Continue reading -> US Food & Drug Administration Approves New Sedative Product For Emergency Use In Ventilated COVID-19 Patients; Doctors Question Remdesivir Eligibility Criteria 12/05/2020 Grace Ren Amidst the global shortage of ventilators, personal protective equipment, and diagnostics; sedatives, used to keep severe COVID-19 patients who require invasive ventilation continuously sedated, are in increasingly short supply around the United States. The US Food and Drug Administration (FDA) on Monday issued an emergency use authorization (EUA) for Fresenius Propoven 2% (propofol 20 mg/mL) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO, Costa Rica & Chile Announce Official Launch Of COVID-19 Intellectual Property Pool 15/05/2020 Grace Ren Costa Rica and the World Health Organization today announced that a voluntary intellectual property pool for COVID-19 related technologies will be officially launched on May 29, following the World Health Assembly on May 18 to 19. The official launch comes more than two months after the Costa Rican president and health minister first published an […] Continue reading -> US Food & Drug Administration Approves New Sedative Product For Emergency Use In Ventilated COVID-19 Patients; Doctors Question Remdesivir Eligibility Criteria 12/05/2020 Grace Ren Amidst the global shortage of ventilators, personal protective equipment, and diagnostics; sedatives, used to keep severe COVID-19 patients who require invasive ventilation continuously sedated, are in increasingly short supply around the United States. The US Food and Drug Administration (FDA) on Monday issued an emergency use authorization (EUA) for Fresenius Propoven 2% (propofol 20 mg/mL) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US Food & Drug Administration Approves New Sedative Product For Emergency Use In Ventilated COVID-19 Patients; Doctors Question Remdesivir Eligibility Criteria 12/05/2020 Grace Ren Amidst the global shortage of ventilators, personal protective equipment, and diagnostics; sedatives, used to keep severe COVID-19 patients who require invasive ventilation continuously sedated, are in increasingly short supply around the United States. The US Food and Drug Administration (FDA) on Monday issued an emergency use authorization (EUA) for Fresenius Propoven 2% (propofol 20 mg/mL) […] Continue reading -> Posts navigation Older postsNewer posts